Quantcast

Miniature Grinding Mill Closes In On The Details Of ‘Green’ Chemical Reactions

Scientists at the University of Cambridge have developed a new approach for observing mechanochemical reactions — where simple ingredients are ground up to make new chemical compounds and materials that can be used in anything from the pharmaceutical to the metallurgical, cement and mineral industries.

Could Acid-Neutralising Life-Forms Make Habitable Pockets In Venus’ Clouds?

A new study shows it’s theoretically possible. The hypothesis could be tested soon with proposed Venus-bound missions.

Latest News

Mystery Of High-Performing Solar Cell Materials Revealed In Stunning Clarity

Researchers have visualised, for the first time, why perovskites – materials which could replace silicon in next-generation solar cells - are seemingly so tolerant of defects in their structure

‘Super Jelly’ Can Survive Being Run Over By A Car

Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80% water.

Simple Treatment During Pregnancy Can Protect Baby From Memory Problems In Later Life, Study In Rats Suggests

A new study in laboratory rats has discovered a direct link between low oxygen in the womb and impaired memory function in the adult offspring. It also finds that anti-oxidant supplements during pregnancy may protect against this.

Artificial Intelligence Could Be Used To Triage Patients Suspected At Risk Of Early-Stage Oesophageal Cancer

Artificial intelligence ‘deep learning’ techniques can be used to triage suspected cases of Barrett oesophagus, a precursor to oesophageal cancer, potentially leading to faster and earlier diagnoses, say researchers at the University of Cambridge.

Stress Does Not Lead To Loss Of Self-Control In Eating Disorders, Study Finds

A unique residential study has concluded that, contrary to perceived wisdom, people with eating disorders do not lose self-control – leading to binge-eating – in response to stress

Scientists Develop New Class Of Cancer Drug With Potential To Treat Leukaemia

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.

Researchers Call For Greater Awareness Of Unintended Consequences Of CRISPR Gene Editing

CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed.

Gene Therapy Technique Shows Potential For Repairing Damage Caused By Glaucoma And Dementia

Scientists at the University of Cambridge have shown in animal studies that gene therapy may help repair some of the damage caused in chronic neurodegenerative conditions such as glaucoma and dementia

Widespread Use Of Control Measures Such As Facemasks Is Vital To Suppress The Pandemic As Lockdown Lifts, Say Scientists

A new mathematical model suggests that the easing of lockdown must be accompanied by wider and more effective use of control measures such as facemasks, even with vaccination, in order to suppress COVID-19 more quickly and reduce the likelihood of another lockdown.

Autism Rates Have Increased And Show Differences In Ethnic Minorities And Links To Social Disadvantage

Around one in 57 (1.76%) children in the UK is on the autistic spectrum, significantly higher than previously reported, according to a study of more than seven million children carried out by researchers from the University of Cambridge’s Department of Psychiatry, in collaboration with researchers from Newcastle University and Maastricht University.

New Genetic Clues Point To New Treatments For ‘Silent’ Stroke

Scientists have identified new genetic clues in people who have had small and often apparently ‘silent’ strokes that are difficult to treat and a major cause of vascular dementia, according to research led by the University of Cambridge and published in The Lancet Neurology.

Machine Learning Models For Diagnosing COVID-19 Are Not Yet Suitable For Clinical Use

Systematic review finds that machine learning models for detecting and diagnosing COVID-19 from medical images have major flaws and biases, making them unsuitable for use in patients. However, researchers have suggested ways to remedy the problem.

Pandemic Restrictions Aggravating Known Triggers For Self-Harm And Poor Mental Health Among Children And Young People

Experts have issued a stark warning about the effects of the pandemic on the mental health of children and young people.

Sugar Purchased In Soft Drinks Fell 10% Following Introduction Of Industry Levy

The amount of sugar purchased by households through soft drinks fell by 10% in the year following the introduction of the UK Soft Drinks Industry Levy, say researchers at the University of Cambridge.

Diphtheria Risks Becoming ‘Major Global Threat’ Again As It Evolves Resistance To Antimicrobials

Diphtheria – a relatively easily-preventable infection – is evolving to become resistant to a number of classes of antibiotics and in future could lead to vaccine escape, warn researchers from the UK and India.

Genomics Study Identifies Routes Of Transmission Of Coronavirus In Care Homes

Genomic surveillance – using information about genetic differences between virus samples – can help identify how SARS-CoV-2 spreads in care home settings, whose residents are at particular risk, according to new research published today.

Identification Of ‘Violent’ Processes That Cause Wheezing Could Lead To Better Diagnosis And Treatment For Lung Disease

A team of engineers has identified the ‘violent’ physical processes at work inside the lungs which cause wheezing, a condition that affects up to a quarter of the world’s population.

Single Dose Of Pfizer Biontech Vaccine Reduces Asymptomatic Infections And Potential For SARS-Cov-2 Transmission

New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.